Hepion Pharms Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,779 | 12,983 | 6,138 | 10,552 | 3,028 |
| TOTAL | $8,937 | $13,193 | $6,559 | $10,859 | $3,613 |
| Non-Current Assets | |||||
| PPE Net | 62 | 68 | 72 | 80 | 74 |
| Intangibles | 1,871 | 1,871 | 1,871 | 1,871 | 1,871 |
| Other Non-Current Assets | 3,251 | 3,253 | 3,258 | 3,258 | 3,258 |
| TOTAL | $5,184 | $5,192 | $5,201 | $5,209 | $5,203 |
| Total Assets | $14,121 | $18,385 | $11,760 | $16,068 | $8,817 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,483 | 1,627 | 1,563 | 2,303 | 4,397 |
| Accrued Expenses | 1,328 | 1,318 | 911 | 921 | 765 |
| TOTAL | $2,811 | $2,945 | $2,474 | $3,224 | $5,162 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,048 | 5,112 | 8,402 | 5,697 | 5,381 |
| TOTAL | $6,318 | $6,382 | $9,672 | $6,966 | $6,650 |
| Total Liabilities | $9,128 | $9,327 | $12,145 | $10,190 | $11,813 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,278 | N/A | 63,707 | 62,780 | 59,945 |
| Common Shares | 8 | 8 | 6 | 6 | 6 |
| Retained earnings | -65,278 | -59,504 | -61,554 | -53,935 | -49,429 |
| Other shareholders' equity | 1,040 | 1,040 | 1,040 | 1,231 | 1,831 |
| TOTAL | $4,993 | $9,058 | $-385 | $5,878 | $-2,996 |
| Total Liabilities And Equity | $14,121 | $18,385 | $11,760 | $16,068 | $8,817 |